Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study

You may be eligible if

• 1. Subjects who completed study ApoGraft-01 through 180 days (6 months) post-transplantation
• 2. Ability to comply with the requirements of the study.
• 3. Signed written informed consent